Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis
| Autor: | Spoletini, G., Gillgrass, L., Pollard, K., Shaw, N., Williams, E., Etherington, C., Clifton, I.J., Peckham, D.G. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis November 2022 21(6):1061-1065 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect